# CHEERS Checklist: Cost-Effectiveness of Type 1 Diabetes Interventions in Resource-Limited Settings

## Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Statement

| Item | CHEERS Item | Recommendation | Location in Manuscript | Compliance |
|------|-------------|----------------|------------------------|------------|
| **Title and Abstract** |
| 1 | Title | Identify the study as an economic evaluation and specify the interventions being compared | Title page | ✓ |
| 2 | Abstract | Provide a structured summary that highlights context, key methods, results, and alternative analyses | Abstract section | ✓ |
| **Introduction and Methods** |
| 3 | Background and objectives | Give the context for the study, the study question, and its relevance for policy or practice | Introduction | ✓ |
| 4 | Health economic analysis plan | Indicate whether a health economic analysis plan was developed and where available | Methods | ✓ |
| 5 | Study population | Describe characteristics of the study population | Methods - Study Population | ✓ |
| 6 | Setting and location | Provide relevant contextual information that may influence findings | Methods - Study Design and Setting | ✓ |
| 7 | Comparators | Describe the interventions or strategies being compared and state why chosen | Methods - Intervention Identification | ✓ |
| 8 | Perspective | State and justify the perspective(s) adopted by the study | Methods - Study Design | ✓ |
| 9 | Time horizon | State and justify the time horizon(s) over which costs, outcomes, or both are being evaluated | Methods - Study Design | ✓ |
| 10 | Discount rate | If applicable, report the discount rate(s) and justify the choice | Methods - Statistical Analysis | ✓ |
| 11 | Selection of outcomes | Describe what outcomes were used as the measure(s) of benefit in the evaluation and their relevance for the type of analysis performed | Methods - Intervention Effects | ✓ |
| 12 | Measurement of effectiveness | Describe how effectiveness was measured, including details of any clinical study that effectiveness data were based on | Methods - Microsimulation Model Structure | ✓ |
| 13 | Measurement and valuation of preference-based outcomes | If applicable, describe the population and methods used to measure and value preference-based outcomes | Methods - Statistical Analysis | ✓ |
| 14 | Estimating resources and costs | Describe how costs were estimated, including details of any clinical study that resource use data were based on | Methods - Intervention Effects and Cost Analysis | ✓ |
| 15 | Currency, price date, and conversion | Report the dates of the estimated resource quantities and unit costs, plus the currency and year of costs presented. Describe methods for adjusting to local currency and price year if applicable | Methods - Intervention Effects and Cost Analysis | ✓ |
| 16 | Rationale for model structure | If modelling is used, describe and justify the structure, the key parameters, and assumptions used | Methods - Microsimulation Model Structure | ✓ |
| 17 | Analytics and assumptions | Describe any methods for analysing or statistically transforming data, any extrapolation methods, and approaches for validating any model used | Methods - Statistical Analysis | ✓ |
| **Results** |
| 18 | Study parameters | Report all analytic inputs (e.g., values, ranges, references) including uncertainty or distributional assumptions | Results - Tables 1-2 | ✓ |
| 19 | Summary of baseline data | Report baseline characteristics of the study population | Results - Microsimulation Analysis | ✓ |
| 20 | Base-case results | For each intervention, report appropriate measures of beneficial outcome(s) and cost(s), and incremental cost-effectiveness | Results - Individual and Cluster Results | ✓ |
| 21 | Effect of uncertainty | Describe how uncertainty was handled and report the effect on the results | Results - All sections with 95% CIs | ✓ |
| 22 | Effect of engagement with patients and others | If applicable, report how patients and others were engaged in the design and conduct of the study | Methods - Expert Validation | ✓ |
| **Discussion and Other** |
| 23 | Study findings, limitations, generalisability, and current knowledge | Summarise the main findings, describe limitations, discuss generalisability, and relate findings to current knowledge | Discussion | ✓ |
| 24 | Source of funding | Describe how the study was funded and any role of the funder in the identification, design, conduct, and reporting of the analysis | Funding statement | ✓ |
| 25 | Conflicts of interest | Report author conflicts of interest according to journal or International Committee of Medical Journal Editors requirements | Author declarations | ✓ |

**Reference:** Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMJ. 2022;376:e067975.

